Percutaneous transuterine fetal cerebral embolisation to treat vein of Galen malformations at risk of urgent neonatal decompensation: study protocol for a clinical trial of safety and feasibility

• Published in: BMJ open Vol. 12; no. 5; p. e058147
• Main Authors: See, Alfred Pokmeng, Wilkins-Haug, Louise E, Benson, Carol B, Tworetzky, Wayne, Orbach, Darren B
• Format: Journal Article
• Language: English
• Published: England British Medical Journal Publishing Group 24-05-2022; BMJ Publishing Group LTD; BMJ Publishing Group
• Series: Protocol
• Subjects: cerebral veins; Child; Clinical outcomes; Clinical trials; Embolization; Embolization, Therapeutic - methods; Feasibility Studies; Female; fetal embolization; fetal therapies; Fetus - diagnostic imaging; Fetuses; Humans; Infant, Newborn; Intervention; Magnetic Resonance Imaging; Morbidity; Mortality; Newborn babies; Obstetrics and Gynaecology; Physiology; Pregnancy; Sinuses; Systematic review; Traumatic brain injury; vein of Galen malformations; Vein of Galen Malformations - diagnostic imaging; Vein of Galen Malformations - pathology; Vein of Galen Malformations - therapy; Veins & arteries; United Kingdom > UK; cerebral veins; vein of Galen malformations; fetal therapies; fetal embolization
• ISSN: 2044-6055; 2044-6055
• DOI: 10.1136/bmjopen-2021-058147

IntroductionAlthough endovascular techniques have improved outcomes in vein of Galen malformations (VOGM), there is still a high rate of morbidity and mortality, particularly among cases with decompensation in the neonatal period. The dimension of the draining venous sinus on fetal imaging correlates with the risk of neonatal decompensation. In fetuses within this high-risk group who do not have end-organ injury, there is a theoretical therapeutic opportunity to reduce the arteriovenous shunt before the normal physiological changes of birth precipitate decompensation. This study investigates the safety and potential benefit of treating a VOGM in utero, which has not been previously studied.Methods and analysisThis study aims to enroll 20 subjects: pregnant women with a fetus harbouring a high-risk VOGM (defined on MRI by a narrowest medial-lateral width greater than 8 mm in the draining venous sinus). Unfortunately, the subset of fetuses with in utero end-organ injury is ineligible, because the late stage of pathology is not amenable to recovery from a cerebrovascular intervention, likely not even in utero. This study aims to alter the physiology before such developments accrue.At or after 23 weeks of gestation, a transuterine transposterior fontanelle needle puncture to the torcular allows ultrasound-guided deployment of coils to embolise the draining venous malformation.This study has 97.5% power to detect major safety events at 30% or greater, and 80% power to detect a reduction in the rate of neonatal intervention from 80% to 30%. In the staged study design, an interval evaluation after 11 patients invokes study termination if safety events occur above the allowed threshold.Ethics and disseminationThe institutional review boards at Mass General Brigham and Boston Children’s Hospital (BCH) reviewed and approved this protocol. The BCH Department of Radiology and a patient family philanthropic donation fund this study. The trial results will be published in peer-reviewed journals and presented at scientific conferences.Trial registration number NCT04434729